9/1/2021Junshi Bio and Coherus Completes Rolling BLA Submission of Toripalimab...

9/1/2021CStone Files Chinese NDA of Sugemalimab for Stage III NSCLC

9/1/2021Harbour BioMed Gets Chinese IND Approval for PII Trial of Anti-FcRn Ba...

8/31/2021NHSA Issues the Notice on the Public Service Item List of Centralized ...

8/31/2021Financial-related Company News in Brief (August 2021)

8/31/2021Eight Central Government Agencies Issues the Pilot Plan for Deepening ...

8/31/2021Jingxin In-licenses Epilepsy Drug from Bio-Pharm Solutions for $40M

8/30/2021NMPA Issues the Notice on Deepening Certification and Licensing Separa...

8/30/2021Ligand's Partner Gloria Bio Wins Chinese Approval for Zimberelimab

8/30/2021Winners and Losers in China's Sweeping Private-Sector Crackdown

8/29/2021NHSA Concludes the List of Drugs Passing Form Evaluation for Inclusion...

8/27/2021Junshi Bio Granted Chinese IND Approval for Subcutaneous Injection of ...

8/27/2021CDE Issues Three Guidance Documents on Non-clinical Research of Nanome...

8/27/2021Recent Executive Moves

8/27/2021Chinese Patent Linkage, Patent Term Adjustment, and Patent Term Extens...

8/25/2021IQVIA: Chinese Hospital Drug Market Rose 14.2% in MAT Q2/2021

8/25/2021Alphamab and CSPC Enter Licensing Deal on Anti-HER2 bsAntibody KN026 i...

8/24/2021Review of Top Ten Overseas Out-licensing Deals of Domestic Phama Compa...

8/24/2021IQVIA: Overall Chinese Pharma Market Growth down 7.9% in 2020

8/23/2021BeiGene Announces Acceptance of a sBLA in China for Tislelizumab in Na...

8/23/2021Lonza Expands Guangzhou Manufacturing Facility with a Fill-finish Line

8/23/2021BioDuro-Sundia Acquires US-based Phase III/Commercial Drug Product Man...

8/20/2021Novartis Receives Approval for Lucentis and Launches Galvus in China

8/20/2021Recent Executive Moves

8/19/2021Adagene Announces the Third Clinical Trial Collaboration with Merck to...

8/18/2021BeiGene and EUSA Pharma Announce NMPA Approval of QARZIBA (Dinutuximab...

8/18/2021HiberCell Takes Over Gentility Science, Formerly Known as WuxiNextcode...

8/18/2021Novartis Secures New Chinese Approval for Cosentyx (Secukinumab) in Pe...

8/18/2021Junshi and Coherus Announce U.S. FDA Breakthrough Therapy Designation ...

8/17/2021Amgen Secures Chinese Approval of Its Psoriasis Drug Otezla (Apremilas...

Page:83/357 Total number of articles:10681: [First][<<] [81] [82] [83] [84] [85] [>>] [End]